Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

reeclampsia and Gestational Hypertension: Biochemical and Antioxidant Features in Vitro Might Help Understand Different Outcome

Full text
Author(s):
Galvao, Victoria Elizabeth [1] ; Cavalli, Ricardo Carvalho [2] ; Sandrim, Valeria Cristina [1, 3]
Total Authors: 3
Affiliation:
[1] Univ Estadual Paulista, Inst Biociencias, Dept Pharmacol, Botucatu, SP - Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, SP - Brazil
[3] Univ Estadual Paulista, Ctr Toxicol Assistance, Inst Biociencias, Botucatu, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Revista Brasileira de Ginecologia e Obstetrícia; v. 43, n. 12, p. 894-903, DEC 2021.
Web of Science Citations: 0
Abstract

Objective Gestational hypertension (GH) is characterized by increased blood pressure after the 20 (th) gestational week; the presence of proteinuria and/or signs of end-organ damage indicate preeclampsia (PE). Heme oxygenase-1 (HO-1) is an antioxidant enzyme with an important role in maintaining endothelial function, and induction of HO-1 by certain molecules shows potential in attenuating the condition's effects over endothelial tissue. HO-1 production can also be stimulated by potassium iodide (KI). Therefore, we evaluated the effects of KI over HO-1 expression in human umbilical vein endothelial cells (HUVECs) incubated with plasma from women diagnosed with GH or PE. Methods Human umbilical vein endothelial cells were incubated with a pool of plasma of healthy pregnant women ( n = 12), pregnant women diagnosed with GH ( n = 10) or preeclamptic women ( n = 11) with or without the addition of KI for 24 hours to evaluate its effect on this enzyme expression. Analysis of variance was performed followed by Dunnet's test for multiple comparisons between groups only or between groups with addition of KI ( p <= 0.05). Results KI solution (1,000 mu M) reduced HO-1 in the gestational hypertension group ( p = 0.0018) and cytotoxicity in the preeclamptic group ( p = 0.0143); treatment with KI reduced plasma cytotoxicity but did not affect the preeclamptic group's HO-1 expression. Conclusion Our findings suggest that KI alleviates oxidative stress leading to decreased HO-1 expression; plasma from preeclamptic women did not induce the enzyme's expression in HUVECs, and we hypothesize that this is possibly due to inhibitory post-transcriptional mechanisms in response to overexpression of this enzyme during early pregnancy. (AU)

FAPESP's process: 15/20461-8 - Role of NRF2 and HO-1 in preeclampsia: polymorphisms, circulating factors and in vitro assays
Grantee:Valeria Cristina Sandrim
Support Opportunities: Regular Research Grants
FAPESP's process: 17/09140-0 - Effects of iodine treatment over Nrf2 and HO-1 expression in an in vitro model of pre-eclampsia
Grantee:Victoria Elizabeth Galvão
Support Opportunities: Scholarships in Brazil - Master